Abstract:Chronic pain is supported by sterile inflammation that induces sensitisation of sensory neurons to ambient stimuli including extracellular ATP acting on purinergic P2X receptors. The development of in vitro methods for drug screening would be useful to investigate cell crosstalk and plasticity mechanisms occurring during neuronal sensitisation and sterile neuroinflammation. Thus, we studied, at single-cell level, membrane pore dilation based on the uptake of a fluorescent probe following sustained ATP-gated P2X receptor function in neurons and non-neuronal cells of trigeminal ganglion cultures from wild-type (WT) and R192Q CaV2.1 knock-in (KI) mice, a model of familial hemiplegic migraine type 1 characterised by neuronal sensitisation and higher release of soluble mediators. In WT cultures, pore responses were mainly evoked by ATP rather than benzoyl-ATP (BzATP) and partly inhibited by the P2X antagonist TNP-ATP. P2X7 receptors were expressed in trigeminal ganglia mainly by non-neuronal cells. In contrast, KI cultures showed higher expression of P2X7 receptors, stronger responses to BzATP, an effect largely prevented by prior administration of CaV2.1 blocker ω-agatoxin IVA, small interfering RNA (siRNA)-based silencing of P2X7 receptors or the P2X7 antagonist A-804598. No cell toxicity was detected with the protocols. Calcitonin gene-related peptide (CGRP), a well-known migraine mediator, potentiated BzATP-evoked membrane permeability in WT as well as R192Q KI cultures, demonstrating its modulatory role on trigeminal sensory ganglia. Our results show an advantageous experimental approach to dissect pharmacological properties potentially relevant to chronic pain and suggest that CGRP is a soluble mediator influencing purinergic P2X pore dilation and regulating inflammatory responses.

New Frontiers in Probing the Dynamics of Purinergic Transmitters in Vivo

Pushing the Frontiers: Tools for Monitoring Neurotransmitters and Neuromodulators.

The New Methods of Purinergic Signalling Research

Development and Application of Nano-Optogenetic Probes

Current and emerging methods for probing neuropeptide transmission

Neuromodulator and neuropeptide sensors and probes for precise circuit interrogation in vivo

Editorial - Purinergic signalling: 50 years

Recent Advances In Detection Methods For Neurotransmitters

An integrated microfluidic and fluorescence platform for probing in vivo neuropharmacology

Genetically Encoded Sensors for the in Vivo Detection of Neurochemical Dynamics.

Neuronal Activity-Induced, Equilibrative Nucleoside Transporter-Dependent, Somatodendritic Adenosine Release Revealed by a GRAB Sensor.

Comprehensive Insights into Potential Roles of Purinergic P2 Receptors on Diseases: Signaling Pathways Involved and Potential Therapeutics

The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators

Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits

Real-Time Monitoring of Neurotransmitters in the Brain of Living Animals

A sensitive GRAB sensor for detecting extracellular ATP in vitro and in vivo

Purinergic Signaling： a Novel Mechanism in Immune Surveillance

Lighting Up the Brain: Genetically Encoded Fluorescent Sensors for Imaging Neurotransmitters and Neuromodulators

A GRAB Sensor Reveals Activity-Dependent Non-Vesicular Somatodendritic Adenosine Release

In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro

State-of-the-art: Functional Fluorescent Probes for Bioimaging and Pharmacological Research